Hosted by Ian Khan, a globally recognised futurist and technology expert, this Future Investment Initiative (FII 2025) interview explores how AI and biotech are converging to revolutionise healthcare, precision medicine and drug development. Ian engages with Dr. Thomas Clozel to uncover the strategic, technological and human‑impact dimensions of this transformation.
Dr. Thomas Clozel is the Co‑Founder & Chief Executive Officer of Owkin, a French‑American AI‑biotech company that uses federated learning and multimodal patient data to accelerate drug discovery, develop diagnostics, and enhance patient outcomes. A former assistant professor of clinical onco‑hematology in Paris and researcher at Weill Cornell, Dr. Clozel leads the mission to “find the right treatment for every patient” through innovative AI‑driven platforms.

Ian Khan is a globally recognised emerging tech leadership expert. A practising Futurist, Creator of the Future Readiness Leaders Circle, Multiple times author including "Metaverse for Dummies", Filmmaker and Storyteller on PrimeVideo and Emirates Airlines, one of the worlds largest airlines with 10 Million passengers per year. Ian's ground breaking work has been featured on CNN, the BBC, Fox, Bloomberg, Wharton Daily, ArabNews, RT, CoinBase, Korea Times, Spanish Daily Expansión, Ian hosts the worlds largest Future Readiness leadership networks, bringing together high performance entrepreneurs and leaders on a common mission to build future ready and undisputable businesses. Khan's new book is titled "Undisruptable" and is scheduled to release in early 2024.
Visit Ian at www.IanKhan.com